4JFY image
Entry Detail
PDB ID:
4JFY
Keywords:
Title:
Apo structure of phosphotyrosine (pYAb) scaffold
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2013-02-28
Release Date:
2013-08-28
Method Details:
Experimental Method:
Resolution:
2.63 Å
R-Value Free:
0.23
R-Value Work:
0.18
R-Value Observed:
0.19
Space Group:
P 32 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Fab light chain
Chain IDs:A, C (auth: L)
Chain Length:214
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Fab heavy chain
Chain IDs:B, D (auth: H)
Chain Length:235
Number of Molecules:2
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Nature-inspired design of motif-specific antibody scaffolds.
Nat.Biotechnol. 31 916 921 (2013)
PMID: 23955275 DOI: 10.1038/nbt.2672

Abstact

Aberrant changes in post-translational modifications (PTMs) such as phosphate groups underlie a majority of human diseases. However, detection and quantification of PTMs for diagnostic or biomarker applications often require PTM-specific monoclonal antibodies (mAbs), which are challenging to generate using traditional antibody-selection methods. Here we outline a general strategy for producing synthetic, PTM-specific mAbs by engineering a motif-specific 'hot spot' into an antibody scaffold. Inspired by a natural phosphate-binding motif, we designed and selected mAb scaffolds with hot spots specific for phosphoserine, phosphothreonine or phosphotyrosine. Crystal structures of the phospho-specific mAbs revealed two distinct modes of phosphoresidue recognition. Our data suggest that each hot spot functions independently of the surrounding scaffold, as phage display antibody libraries using these scaffolds yielded >50 phospho- and target-specific mAbs against 70% of target peptides. Our motif-specific scaffold strategy may provide a general solution for rapid, robust development of anti-PTM mAbs for signaling, diagnostic and therapeutic applications.

Legend

Protein

Chemical

Disease

Primary Citation of related structures